JO
CELL

John Overdeck’s PhenomeX Inc. Common Stock CELL Stock Holding History

John Overdeck’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,384
Closed -$20.3K – 3477
2023
Q3 		$20.3K Sell
20,384
-84,918
-81% -$65.1K ﹤0.01% 2871
2023
Q2 		$51.6K Buy
+105,302
New +$86.1K ﹤0.01% 2824
2023
Q1 		– Sell
-171,945
Closed -$461K – 3297
2022
Q4 		$461K Buy
171,945
+13,644
+9% +$36K ﹤0.01% 2056
2022
Q3 		$453K Sell
158,301
-148,767
-48% -$633K ﹤0.01% 1822
2022
Q2 		$1.53M Sell
307,068
-720,307
-70% -$3.77M 0.01% 1336
2022
Q1 		$7.3M Sell
1,027,375
-50,594
-5% -$419K 0.02% 736
2021
Q4 		$19.6M Sell
1,077,969
-72,441
-6% -$1.56M 0.04% 483
2021
Q3 		$22.5M Buy
1,150,410
+792,780
+222% +$30.1M 0.05% 431
2021
Q2 		$16M Sell
357,630
-267,352
-43% -$12.4M 0.04% 587
2021
Q1 		$31.4M Buy
+624,982
New +$42.6M 0.08% 280

John Overdeck's CELL Position: Q4 2023 in Review

John Overdeck sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 20,384 shares — an estimated $20.3K sold.

John Overdeck first reported a position in CELL in Q1 2021 and held it in 10 quarters. The position peaked at $31.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • John Overdeck reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • John Overdeck sold 20,384 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $20.3K.
  • John Overdeck first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • John Overdeck's PhenomeX Inc. Common Stock position peaked at $31.4M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.